PD-1 is a novel regulator of human B-cell activation (Q39533046)

12 September 2017

title

PD-1 is a novel regulator of human B-cell activation (English)

1 reference

12 September 2017

2

Emilie Mamessier

0 references

Marie-Laure Thibult

1

object named as

Marie-Laure Thibult

0 references

Julie Gertner-Dardenne

object named as

Julie Gertner-Dardenne

0 references

author name string

Marie-Laure Thibult

1

1 reference

12 September 2017

Emilie Mamessier

2

1 reference

12 September 2017

Julie Gertner-Dardenne

3

1 reference

12 September 2017

Sonia Pastor

4

1 reference

12 September 2017

Sylvaine Just-Landi

5

1 reference

12 September 2017

Luc Xerri

6

1 reference

12 September 2017

Bruno Chetaille

7

1 reference

12 September 2017

Daniel Olive

8

1 reference

12 September 2017

publication date

18 October 2012

1 reference

12 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

International Immunology

1 reference

12 September 2017

volume

25

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

129-137

1 reference

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Peripheral development of B cells in mouse and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Points of control in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXS098

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/J.1460-2075.1992.TB05481.X

Expression of programmed death 1 ligands by murine T cells and APC

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.4049/JIMMUNOL.169.10.5538

Identifiers

DOI

10.1093/INTIMM/DXS098

1 reference

release_xzh6a6cztvd5jdvt64bfcyap4e

12 September 2017

Fatcat ID

0 references

1 reference